Transition Therapeutics Inc (NASDAQ:TTHI)

Delayed Data
As of Mar 27
 -0.0412 / -0.60%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Transition Therapeutics Inc have a median target of 10.00, with a high estimate of 10.39 and a low estimate of 8.63. The median estimate represents a +46.41% increase from the last price of 6.83.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Transition Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 68.63%
Growthannually -55.94%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account